Airaksinen M, Saarma M (2002). "The GDNF family: signalling, biological functions and therapeutic value". Nat Rev Neurosci. 3 (5): 383–94. doi:10.1038/nrn812. PMID11988777. S2CID2480120.
Arighi E, Borrello MG, Sariola H (2005). "RET tyrosine kinase signaling in development and cancer". Cytokine Growth Factor Rev. 16 (4–5): 441–467. doi:10.1016/j.cytogfr.2005.05.010. PMID15982921.
Barnett MW, Fisher CE, et al. (2002). "Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulfate glycosaminoglycan". J. Cell Sci. 115 (23): 4495–4503. doi:10.1242/jcs.00114. PMID12414995. S2CID5910562.
Gill S, Patel N, Hotton G, O'Sullivan K, McCarter R, Bunnage M, Brooks D, Svendsen C, Heywood P (2003). "Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease". Nat Med. 9 (5): 589–95. doi:10.1038/nm850. PMID12669033. S2CID3331090.
Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B (2005). "Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor". J. Neurosurg. 102 (2): 216–22. doi:10.3171/jns.2005.102.2.0216. PMID15739547.
Henderson C, Phillips H, Pollock R, Davies A, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen R, Simpson L, et al. (1994). "GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle". Science. 266 (5187): 1062–1064. Bibcode:1994Sci...266.1062H. doi:10.1126/science.7973664. PMID7973664.
Airavaara M, Planken A, Gäddnäs H, Piepponen T, Saarma M, Ahtee L (2004). "Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice". Eur J Neurosci. 20 (9): 2336–2344. doi:10.1111/j.1460-9568.2004.03700.x. PMID15525275. S2CID24973132.
Golden J, Milbrandt J, Johnson E (2003). "Neurturin and persephin promote the survival of embryonic basal forebrain cholinergic neurons in vitro". Exp Neurol. 184 (1): 447–55. doi:10.1016/j.expneurol.2003.07.999. PMID14637114. S2CID28406766.
Airaksinen M, Saarma M (2002). "The GDNF family: signalling, biological functions and therapeutic value". Nat Rev Neurosci. 3 (5): 383–94. doi:10.1038/nrn812. PMID11988777. S2CID2480120.
Arighi E, Borrello MG, Sariola H (2005). "RET tyrosine kinase signaling in development and cancer". Cytokine Growth Factor Rev. 16 (4–5): 441–467. doi:10.1016/j.cytogfr.2005.05.010. PMID15982921.
Barnett MW, Fisher CE, et al. (2002). "Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulfate glycosaminoglycan". J. Cell Sci. 115 (23): 4495–4503. doi:10.1242/jcs.00114. PMID12414995. S2CID5910562.
Gill S, Patel N, Hotton G, O'Sullivan K, McCarter R, Bunnage M, Brooks D, Svendsen C, Heywood P (2003). "Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease". Nat Med. 9 (5): 589–95. doi:10.1038/nm850. PMID12669033. S2CID3331090.
Slevin JT, Gerhardt GA, Smith CD, Gash DM, Kryscio R, Young B (2005). "Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor". J. Neurosurg. 102 (2): 216–22. doi:10.3171/jns.2005.102.2.0216. PMID15739547.
Henderson C, Phillips H, Pollock R, Davies A, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen R, Simpson L, et al. (1994). "GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle". Science. 266 (5187): 1062–1064. Bibcode:1994Sci...266.1062H. doi:10.1126/science.7973664. PMID7973664.
Airavaara M, Planken A, Gäddnäs H, Piepponen T, Saarma M, Ahtee L (2004). "Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice". Eur J Neurosci. 20 (9): 2336–2344. doi:10.1111/j.1460-9568.2004.03700.x. PMID15525275. S2CID24973132.
Golden J, Milbrandt J, Johnson E (2003). "Neurturin and persephin promote the survival of embryonic basal forebrain cholinergic neurons in vitro". Exp Neurol. 184 (1): 447–55. doi:10.1016/j.expneurol.2003.07.999. PMID14637114. S2CID28406766.
Airaksinen M, Saarma M (2002). "The GDNF family: signalling, biological functions and therapeutic value". Nat Rev Neurosci. 3 (5): 383–94. doi:10.1038/nrn812. PMID11988777. S2CID2480120.
Barnett MW, Fisher CE, et al. (2002). "Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulfate glycosaminoglycan". J. Cell Sci. 115 (23): 4495–4503. doi:10.1242/jcs.00114. PMID12414995. S2CID5910562.
Gill S, Patel N, Hotton G, O'Sullivan K, McCarter R, Bunnage M, Brooks D, Svendsen C, Heywood P (2003). "Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease". Nat Med. 9 (5): 589–95. doi:10.1038/nm850. PMID12669033. S2CID3331090.
Airavaara M, Planken A, Gäddnäs H, Piepponen T, Saarma M, Ahtee L (2004). "Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice". Eur J Neurosci. 20 (9): 2336–2344. doi:10.1111/j.1460-9568.2004.03700.x. PMID15525275. S2CID24973132.
Golden J, Milbrandt J, Johnson E (2003). "Neurturin and persephin promote the survival of embryonic basal forebrain cholinergic neurons in vitro". Exp Neurol. 184 (1): 447–55. doi:10.1016/j.expneurol.2003.07.999. PMID14637114. S2CID28406766.
Gardell L, Wang R, Ehrenfels C, Ossipov M, Rossomando A, Miller S, Buckley C, Cai A, Tse A, Foley S, Gong B, Walus L, Carmillo P, Worley D, Huang C, Engber T, Pepinsky B, Cate R, Vanderah T, Lai J, Sah D, Porreca F (2003). "Multiple actions of systemic artemin in experimental neuropathy". Nat Med. 9 (11): 1383–1389. doi:10.1038/nm944. PMID14528299. S2CID24449754.